DCGI okays human clinical trial of Covid vaccineJuly 03, 2020 08:16
The Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine, a top government official told ANI.
The move comes as a rapid response after recommendation by the subject expert committee as approved by DCGI.
"The company has submitted data to DCGI based on animal trial, they conducted. Animals like- mice, rabbits, guinea pigs, rats were used and these animals developed antibodies against the virus," a senior government official told ANI.
"Their animal trial data was inspected thoroughly and was found satisfactory. And now, DCGI has granted permission to Zydus Cadila to conduct Phase I & II clinical trial for COVID -19 vaccine on humans after successful animal trial," said the official.
So far, India has two indigenous manufacturers for the potential COVID-19 vaccine.
In the recent past, DCGI has given permission to Bharat Biotech International Limited (BBIL), who has partnered with the Indian Council of Medical Research (ICMR) to conduct Phase I & II human clinical trials to develop an indigenous vaccine for COVID-19 -- in the name COVAXIN.
The Bharat Biotech using the virus strain isolated at ICMR's National Institute of Virology (NIV), Pune to develop the vaccine. -- Priyanka Sharma/ANI
Light a diya for soldiers guarding our borders: PM in Mann ki Baat
In his monthly 'Mann ki Baat' radio broadcast, Modi wished people on Dussehra and said that with various festivals coming up, they need to show patience and follow health guidelines in celebrating these auspicious occasions during the...